Literature DB >> 6796316

Selective deficiency of the fourth component of complement in a patient with systemic lupus erythematosus (SLE): immunochemical and biological studies.

J O Minta, M B Urowitz, D D Gladman, T Irizawa, W D Biggar.   

Abstract

A 45-year-old female (J.B.) with clinically inactive systemic lupus erythematosus was devoid of haemolytic serum complement activity. Functional and immunoprecipitin assays showed that the complement defect was due to lack of the fourth component of complement (C4). The patient's serum and red cells were Chido-negative, Rodgers-negative. In J.B.'s serum there was marked impairment of opsonization of Staphylococcus aureus and of the formation of chemotactic activity in the presence of zymosan. The chemotactic defect was not due to the presence of inhibitory factors: the activity was increased by the addition of C4. These findings suggest that an intact classical pathway is necessary for the optimal generation of serum chemotactic factors by zymosan via the alternative pathway of the complement system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796316      PMCID: PMC1537245     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

Review 1.  Complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  Human serum lyses RNA tumour viruses.

Authors:  R M Welsh; N R Cooper; F C Jensen; M B Oldstone
Journal:  Nature       Date:  1975-10-16       Impact factor: 49.962

3.  Activation of the alternate pathway of human complements by rabbit cells.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

4.  Chido-substance in plasma.

Authors:  J Middleton; M C Crookston
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

5.  Biosynthesis of the second (C2) and fourth (C4) components of complement in vitro by tissues isolated from guinea-pigs with genetically determined C4 deficiency.

Authors:  H R Colten; M M Frank
Journal:  Immunology       Date:  1972-06       Impact factor: 7.397

6.  Effect of antibiotics on the bactericidal activity of human leukocytes.

Authors:  J W Alexander; R A Good
Journal:  J Lab Clin Med       Date:  1968-06

7.  Analysis of the reactive site peptide bond in C1-inhibitor by chemical modification of tyrosyl, lysyl, and arginyl residues: the essential role of lysyl residues in the functional activity of C1-INH.

Authors:  J O Minta; E Aziz
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

8.  Human C5a and C5a analogs as probes of the neutrophil C5a receptor.

Authors:  D E Chenoweth; T E Hugli
Journal:  Mol Immunol       Date:  1980-02       Impact factor: 4.407

9.  Inherited structural polymorphism of the fourth component of human complement.

Authors:  Z L Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

View more
  4 in total

1.  Selective C4 deficiency, systemic lupus erythematosus, and Whipple's disease.

Authors:  M Ehrenfeld; M B Urowitz; M E Platts
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

2.  Inherited incomplete deficiency of the fourth component of complement (C4) determined by a gene not linked to human histocompatibility leukocyte antigens.

Authors:  W A Muir; S Hedrick; C A Alper; O D Ratnoff; B Schacter; J J Wisnieski
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

3.  Effect on the human complement system of the major non-steroidal anti-inflammatory drugs: aspirin, indomethacin, phenylbutazone, oxyphenbutazone and sulindac.

Authors:  J O Minta; M B Urowitz; H A Smythe; D E Isenman
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

4.  Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus.

Authors:  J D Reveille; F C Arnett; R W Wilson; W B Bias; R H McLean
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.